Karantanos T - Search Results

1

Favorable outcomes in MDS and oligoblastic AML-MR after reduced-intensity conditioning allogeneic bone marrow transplantation with post-transplantation cyclophosphamide.

Sinanidis I, Hochman MJ, Tsai HL, Randall MP, Bonilla B, Varadhan R, Ambinder AJ, Jones RJ, DeZern AE, Karantanos T. Sinanidis I, et al. Among authors: karantanos t. Bone Marrow Transplant. 2024 Aug;59(8):1178-1180. doi: 10.1038/s41409-024-02299-y. Epub 2024 May 7. Bone Marrow Transplant. 2024. PMID: 38714755 No abstract available.

2

Biology and clinical management of hypoplastic MDS: MDS as a bone marrow failure syndrome.

Karantanos T, DeZern AE. Karantanos T, et al. Best Pract Res Clin Haematol. 2021 Jun;34(2):101280. doi: 10.1016/j.beha.2021.101280. Epub 2021 Jun 26. Best Pract Res Clin Haematol. 2021. PMID: 34404534 Review.

3

Acute Myeloid Leukemia Stem Cell Heterogeneity and Its Clinical Relevance.

Karantanos T, Jones RJ. Karantanos T, et al. Adv Exp Med Biol. 2019;1139:153-169. doi: 10.1007/978-3-030-14366-4_9. Adv Exp Med Biol. 2019. PMID: 31134500 Review.

4

Karantanos T, Jain T, Moliterno AR, Jones RJ, DeZern AE. Karantanos T, et al. Int J Mol Sci. 2021 Mar 5;22(5):2595. doi: 10.3390/ijms22052595. Int J Mol Sci. 2021. PMID: 33807519 Free PMC article. Review.

5

Karantanos T, Gondek LP, Varadhan R, Moliterno AR, DeZern AE, Jones RJ, Jain T. Karantanos T, et al. Br J Haematol. 2021 Jun;193(6):1142-1150. doi: 10.1111/bjh.17534. Epub 2021 May 24. Br J Haematol. 2021. PMID: 34028801 Free PMC article.

6

Genomic landscape of myelodysplastic/myeloproliferative neoplasm can predict response to hypomethylating agent therapy.

Karantanos T, Tsai HL, Gondek LP, DeZern AE, Ghiaur G, Dalton WB, Gojo I, Prince GT, Webster J, Ambinder A, Smith BD, Levis MJ, Varadhan R, Jones RJ, Jain T. Karantanos T, et al. Leuk Lymphoma. 2022 Aug;63(8):1942-1948. doi: 10.1080/10428194.2022.2057488. Epub 2022 Apr 4. Leuk Lymphoma. 2022. PMID: 35379077 Free PMC article.

7

Chronic myeloid leukemia (CML) evolves from Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs) with unexpected frequency.

Hochman MJ, Smith BD, Karantanos T, Braunstein EM, Gojo I, Jain T, Streiff MB, Moliterno AR, DeZern AE. Hochman MJ, et al. Among authors: karantanos t. Int J Hematol. 2023 Mar;117(3):456-462. doi: 10.1007/s12185-022-03463-0. Epub 2022 Oct 1. Int J Hematol. 2023. PMID: 36181657 Review.

8

Understanding the Continuum between High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia.

Zavras PD, Sinanidis I, Tsakiroglou P, Karantanos T. Zavras PD, et al. Among authors: karantanos t. Int J Mol Sci. 2023 Mar 6;24(5):5018. doi: 10.3390/ijms24055018. Int J Mol Sci. 2023. PMID: 36902450 Free PMC article. Review.

9

The role of the atypical chemokine receptor CCRL2 in myelodysplastic syndrome and secondary acute myeloid leukemia.

Karantanos T, Teodorescu P, Perkins B, Christodoulou I, Esteb C, Varadhan R, Helmenstine E, Rajkhowa T, Paun BC, Bonifant C, Dalton WB, Gondek LP, Moliterno AR, Levis MJ, Ghiaur G, Jones RJ. Karantanos T, et al. Sci Adv. 2022 Feb 18;8(7):eabl8952. doi: 10.1126/sciadv.abl8952. Epub 2022 Feb 18. Sci Adv. 2022. PMID: 35179961 Free PMC article.

10

Expression of putative leukemia stem cell targets in genetically-defined acute myeloid leukemia subtypes.

Yanagisawa B, Perkins B, Karantanos T, Levis M, Ghiaur G, Smith BD, Jones RJ. Yanagisawa B, et al. Among authors: karantanos t. Leuk Res. 2020 Dec;99:106477. doi: 10.1016/j.leukres.2020.106477. Epub 2020 Nov 10. Leuk Res. 2020. PMID: 33220589 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

81 results

Search Page

Filters